Your mental health and gut health are intertwined, so tending to both is crucial for your wellness and for alleviating nausea during retatrutide
Qualification process for drug development tools guidance for industry and FDA staff
Treatment continuation depends on achieving specified weight loss targets as defined in the product-specific NICE guidance and SmPCs
In clinical studies, liraglutide and semaglutide both led to an average 0.3-point drop in A1c in prediabetic participants (after 56 weeks for liraglutide 5 and 68 weeks for semaglutide 6 )a small but meaningful shift for people whose blood sugar is creeping upward toward the diabetes threshold
ADA 2026 Obesity Drug Updates: Retatrutide, CagriSema, and Oral GLP-1s At the 2026 American Diabetes Association Scientific Sessions, investigators unveiled a wave of late-stage obesity trial results that could reshape clinical practice
GLP-1 is a shortened name for a GLP-1 receptor agonist, or glucagon-like peptide 1 recept agonist